It’s well known that prescription drug prices are skyrocketing in America. Price increases for brand name drugs have far exceeded the rate of inflation since at least 2006, according to AARP’s Rx Price Watch report. And the average annual cost for just one brand name drug taken on a chronic basis was about $6,800 in 2017, almost $1,000 more than in 2015. However, it’s not just patients paying for greedy Big Pharma practices that keep drug prices high— it’s also taxpayers.
As negotiators meet on the Trans-Pacific Partnership (TPP) in Atlanta, AARP is again urging them to be mindful of the consumers who depend on prescription drugs to manage their health conditions. We continue to have serious concerns with the direction of the TPP negotiations on key issues that will have long-lasting effects on access to affordable prescriptions in the U.S. and around the world.
Prescription drug programs that automatically ship out refills at regular intervals can help older Americans follow doctor's orders, according to business organizations that are lobbying against a Medicare crackdown on the practice.
Tax reform proposals are bubbling up in a number of states across the country as elected officials look for ways to stimulate the state's economy or revamp outdated tax codes. Sometimes, however, a key element gets lost in the debate: what's fair.
It's that time of year again; here on the East Coast, we're unpacking our sweaters, and doing a quick inventory of summer, a sort of fall cleaning. Do you do do a seasonal survey of your closet?
AARP Wisconsin was hanging out in Reedsburg this weekend with their new friend Phil The Pill from The P2D2 Program. Who is this mysterious man (bottle?) and what does he want with AARP members?
Search AARP Blogs